SCHEMBL532980

SCHEMBL532980

Cc1ccccc1S(=O)(=O)Nc1c(C)cc(C)c(N2CCCC2)c1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 1/20 0.48
HPGD P15428 4/20 0.45
KDM4E B2RXH2 3/20 0.45
TSHR P16473 1/20 0.45
PPARG P37231 1/20 0.45
NCOA2 Q15596 1/20 0.45
NCOA1 Q15788 1/20 0.45
HTT P42858 3/20 0.43
PLA2G1B P04054 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ATG4B Q9Y4P1 1/20 0.43
ALDH1A1 P00352 6/20 0.42
RXFP1 Q9HBX9 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
EDNRA P25101 1/20 0.42
MAPT P10636 4/20 0.41
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL532939 0.89 EDNRA (0.43) JAK2ALDH1A1L3MBTL1EDNRAMAPT
SCHEMBL534052 0.89 MEN1 (0.47) JAK2TSHRALDH1A1L3MBTL1EDNRA
SCHEMBL532038 0.89 ALDH1A1 (0.54) JAK2KDM4ETSHRALDH1A1EDNRA
SCHEMBL533083 0.87 EDNRA (0.46) JAK2SMN1; SMN2ALDH1A1L3MBTL1EDNRA
SCHEMBL533550 0.87 HCRTR1 (0.47) TSHREDNRAMAPTTP53KMT2A
SCHEMBL8314837 0.86 MAPT (0.39) JAK2TSHRHTTSMN1; SMN2ALDH1A1
SCHEMBL533512 0.86 SLC22A12 (0.44) JAK2KDM4ETSHRHTTALDH1A1
SCHEMBL532998 0.86 JAK2 (0.37) JAK2HPGDKDM4ETSHRPPARG
SCHEMBL532999 0.86 TP53 (0.48) ALDH1A1RXFP1CYP3A4CYP2C9TP53
SCHEMBL532776 0.85 FFAR4 (0.54) TSHRALDH1A1L3MBTL1MAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2415760-A2 CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2012-02-08 EP disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed